Rasagiline 1 mg Oral Tablet
RxNorm 608328
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 608328 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: rasagiline 1 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Rasagiline 1 mg Oral Tablet
(Atom ID: 2385969)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely rasagiline (as rasagiline mesilate) 1 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12666065)
SYPrescribable
Synonym (SY):
Rasagiline (as rasagiline mesilate) 1 mg oral tablet
(Atom ID: 12666190)
SYPrescribable
Synonym (SY):
Rasagiline (as rasagiline mesylate) 1 mg Oral Tablet
(Atom ID: 8712699)
PTPrescribable
Designated preferred name (PT):
Rasagiline (as rasagiline mesylate) 1 mg oral tablet
(Atom ID: 12666192)
PSNPrescribable
Prescribable Name (PSN):
Rasagiline 1 mg Oral Tablet
(Atom ID: 6369006)
Patient Education
Rasagiline
Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.